A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/404 (2006.01) A61K 31/421 (2006.01) A61K 31/425 (2006.01) A61K 31/506 (2006.01) A61K 31/517 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2566104
The present invention relates to a method for treating patients exposed to chemical or biological weapons comprising administering a compound capable of depleting mast cells or a compound inhibiting mast cells degranulation, to a human in need of such treatment. Such compounds can be chosen from c-kit inhibitors and more particularly non-toxic, selective and potent c-kit inhibitors. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.
L'invention concerne un procédé de traitement de patients exposés à des armes chimiques ou biologiques, qui consiste à administrer à un sujet humain un composé capable de réduire le volume de mastocytes ou un composé qui inhibe la dégranulation des mastocytes. Ces composés peuvent être choisis dans le groupe d'inhibiteurs de c-kit, et plus particulièrement, des inhibiteurs de c-kit non toxiques, sélectifs et puissants. De préférence, ledit inhibiteur est incapable de provoquer la mort des cellules dépendantes de l'IL-3 mises en cultures en présence de l'IL-3.
Kinet Jean-Pierre
Moussy Alain
Ab Science
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of mast cells inhibitors for treating patients exposed... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mast cells inhibitors for treating patients exposed..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mast cells inhibitors for treating patients exposed... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1759551